Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	497.97	615.1	905.45	1,431	1,895	94.24
Short-Term Investments	-	13.41	2.09	65.63	367.39	316.65
Cash & Short-Term Investments	497.97	628.5	907.55	1,497	2,263	410.89
Cash Growth	-21.74%	-30.75%	-39.37%	-33.84%	450.69%	201.56%
Accounts Receivable	184.24	149.61	151.71	134.59	110.75	89.73
Other Receivables	-	1.18	0.1	0.11	2.23	81.56
Receivables	189.56	150.79	151.81	138.2	112.98	171.29
Inventory	66.44	69.02	130.32	123.21	68.02	58.12
Restricted Cash	0.28	0.12	19.82	7.8	29.9	4.01
Other Current Assets	30.62	35.67	49.27	54.79	50.06	62.48
Total Current Assets	784.88	884.1	1,259	1,821	2,524	706.79
Property, Plant & Equipment	189.44	144.2	300.03	406.45	111.48	89.31
Long-Term Investments	0.24	0.34	0.69	0.91	1.42	40.16
Other Intangible Assets	0.53	0.96	1.99	5.15	3.46	0.34
Other Long-Term Assets	9.72	5.09	20.89	45.14	23.02	10.95
Total Assets	984.81	1,040	1,587	2,279	2,663	847.56
Accounts Payable	25.21	18.06	50.95	63.08	35.48	12.35
Accrued Expenses	94.11	65.37	104.23	107.03	71.89	44.6
Short-Term Debt	-	-	-	2.37	7.37	2.37
Current Portion of Long-Term Debt	-	-	-	-	34.7	37.13
Current Portion of Leases	27.84	8.63	37.24	35	4.82	4.89
Current Income Taxes Payable	-	20.62	11.03	7.69	6.99	6.38
Current Unearned Revenue	110.75	130.54	147.63	142.87	74.4	49.54
Other Current Liabilities	0.57	20.14	60.38	14.14	5.89	7.18
Total Current Liabilities	258.48	263.36	411.45	372.18	241.53	164.44
Long-Term Debt	-	-	-	-	-	18.27
Long-Term Leases	73.06	3.69	13.55	49.32	-	4.82
Long-Term Unearned Revenue	-	-	-	-	0.26	0.99
Other Long-Term Liabilities	5.1	4.54	4.12	11.78	0.23	-
Total Liabilities	336.64	271.59	429.13	433.28	242.02	188.52
Common Stock	0.14	0.14	0.14	0.14	0.14	0.03
Additional Paid-In Capital	4,997	4,849	4,583	4,281	4,007	45.64
Retained Earnings	-4,119	-3,854	-3,200	-2,229	-1,418	-946.46
Treasury Stock	-65.9	-65.9	-58.92	-	-	-
Comprehensive Income & Other	-164.06	-161.53	-165.72	-207.07	-167.59	9.3
Total Common Equity	648.17	768.41	1,158	1,845	2,421	-891.49
Shareholders' Equity	648.17	768.41	1,158	1,845	2,421	659.04
Total Liabilities & Equity	984.81	1,040	1,587	2,279	2,663	847.56
Total Debt	100.9	12.32	50.79	86.69	46.88	67.47
Net Cash (Debt)	397.07	616.18	856.76	1,410	2,216	343.41
Net Cash Growth	-35.67%	-28.08%	-39.25%	-36.35%	545.24%	-
Net Cash Per Share	38.67	60.18	82.45	135.33	322.84	146.23
Filing Date Shares Outstanding	10.32	10.26	10.27	10.52	10.45	2.5
Total Common Shares Outstanding	10.32	10.24	10.26	10.51	10.48	2.5
Working Capital	526.4	620.73	847.31	1,449	2,282	542.35
Book Value Per Share	62.79	75.01	112.85	175.56	231.05	-356.15
Tangible Book Value	647.64	767.45	1,156	1,840	2,418	-891.84
Tangible Book Value Per Share	62.74	74.92	112.66	175.07	230.72	-356.28
Machinery	-	348.07	339.09	297.89	180.54	138.78
Construction In Progress	-	0.55	2.66	27.56	1.09	0.67
Leasehold Improvements	-	187.39	187.38	161.04	30.67	24.65

Source: S&P Capital IQ. Standard template. Financial Sources.